EADV 2020 Highlights Podcast

 

In this episode, Dr Rachel Giles dives into:

1. 
   
   1. Brodalumab real-world evidence in psoriasis - Von Kiedrowski et al.
   2. Delgocitinib for hand eczema - Worm et al.
   3. JAK1 inhibition successful in hidradenitis suppurativa - Alavi et al.
   4. Secukinumab in kids with severe chronic plaque psoriasis - Bodemer et al
   5. Omalizumab discontinuation in urticaria due to COVID-19 - Gulcan et al.

Posted on 2 November 202027 June 2024